Behavioral and physiological sex differences observed in an animal model of fulminant hepatic encephalopathy in the rat

Physiology and Behavior

Volumn 62, Issue 5, 1997, Pages 1113-1124

  Norton, Neil S ^a   McConnell, James R ^b   Rodriguez Sierra, Jorge F ^c  

^a CREIGHTON UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Behavior; Fulminant hepatic encephalopathy; Hippocampus; Sex differences; Thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; MALE; MORPHOMETRICS; MOTOR DYSFUNCTION; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

EID: 0030850290     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00267-9     Document Type: Article

References (53)

1. Adams, R. D.; Foley, J. M. The neurological disorders associated with liver disease. Res. Pub. - Assoc. Res. Nerv. Ment. Dis. 32:198-237; 1953.
2. Albrecht, J.; Hilgier, W.; Rafalowska, U. Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: An adaptive response? J. Neurosci. Res. 25:125-130; 1990.
3. Albrecht, J.; Rafalowska, U. Enhanced potassium-stimulated γ-aminobutyric acid release by astrocytes derived from rats with early hepatogenic encephalopathy. J. Neurochem. 49:9-11; 1987.
4. Blitzer, B. L.; Waggoner, J. G.; Jones, E. A.; Gralnick, H. R.; Towne, D.; Butler, J.; Weise, V.; Kopin, I. J.; Walters, I.; Teychenne, P. F.; Goodman, D. G.; Berk, P. D. A model of fulminant hepatic failure in the rabbit. Gastroenterology 74:664-671; 1978.
5. Choi, D. W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:369-379; 1987.
6. Collins, J. S. A.; Watt, P. D. H.; Hamilton, P. W.; Sloan, J. M.; Love, A. H. G. Grading of superficial antral gastritis: Comparison of cell-counting and photographic-based methods. J. Pathol. 163:251-256; 1991.
7. Diaz-Munoz, M.; Tapia, R. Regional brain GABA metabolism and release during hepatic coma produced in rats chronically treated with carbon tetrachloride. Neurochem. Res. 13:37-44; 1988.
8. Floersheim, G. L. Treatment of experimental poisoning produced by extracts of Amanita phalloides. Toxicol. Appl. Pharmacol. 34:499-508; 1975.
9. Gammal, S. H.; Jones, E. A. Hepatic encephalopathy. Med. Clin. North Am. 73:793-813; 1989.
10. Geller, D.; Gammal, S. H.; Mullen, K. D.; Jones, E. A. An improved rat model of hepatic encephalopathy due to fulminant hepatic failure: The importance of supportive therapy. In: Soeters, P. B.; Wilson, J. H. P.; Meijer, A. J.; Holm, E., eds. Advances in ammonia metabolism and hepatic encephalopathy. Amsterdam: Excerpta Medica; 1988: 213-217.
11. Gholson, C. F.; McDonald, J.; McMillan, R. Liver transplantation. When is it indicated and what can be expected afterwards? Postgrad. Med. 97:101-104; 1995.
12. Gilberstadt, S. J.; Gilberstadt, H.; Zieve, L.; Buegel, B.; Collier, R. O.; McClain, C. J. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch. Intern. Med. 140:519-521; 1980.
13. Gimson, A. E. S.; White, Y. S.; Eddleston, A. L. W. F; Williams, R. Clinical and prognostic differences in fulminant hepatic failure. Gut 24:1194-1198; 1983.
14. Gitlin, N.; Lewis, D. C.; Hinkley, L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J. Hepatol. 3:75-82; 1986.
15. Hagve, T. A.; Christensen, E.; Gronn, M.; Christophersen, B. O. Regulation of the metabolism of polyunsaturated fatty acids. Scand. J. Clin. Lab. Invest. Suppl. 191:33-46; 1988.
16. 3H]-deoxyglucose. Acta Neurol. Scand. 83:353-355; 1991.
17. 3H]D-aspartate from hippocampal slices distinguishes encephalopathy related to acute liver failure from that induced by simple hyperammonemia. Brain Res. 567:165-168; 1991.
18. Hunter, A. L.; Holscher, M. A.; Neal, R. A. Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system. J. Pharmacol. Exp. Ther. 200:439-448; 1977.
19. Jones, E. A.; Gammal, S. H. Hepatic encephalopathy. In: Arias, I. A.; Jakoby, W. B.; Popper, H.; et al., eds. The liver: Biology and pathobiology. New York: Raven Press; 1988:985-1006.
20. Kamataki, T.; Maeda, K.; Shimada, M.; Kato, R. Effects of phenobarbital, 3-methylcholanthrene and polychlorinated biphenyls on sex-specific forms of cytochrome P-450 in liver microsomes of rats. J. Biochem. Tokyo 99:841-845; 1986.
21. Katelaris, P. H.; Jones, D. B. Fulminant hepatic failure. Med. Clin. North Am. 73:955-970; 1989.
22. Kato, R. Sex-related differences in drug metabolism. Drug Metab. Rev. 3:1-32; 1974.
23. Koh, J. Y.; Goldberg, M. P.; Hartley, D. M.; Choi, D. W. Non-NMDA receptor-mediated neurotoxicity in cortical culture. J. Neurosci. 10: 693-705; 1990.
24. Kojima, T.; Sawada, N.; Zhong, Y.; Oyamada, M.; Mori, M. Sequential changes in intracellular junctions between hepatocytes during the course of acute liver injury and restoration after thioacetamide treatment. Virchows Arch. 425:407-412; 1994.
25. Malt, R. A. Portal systemic shunts. N. Engl. J. Med. 295:24-29; 1976.
26. Mori, W.; Aoyama, H. Statistical study on fulminant liver disease in Japan. Appl. Pathol. 1:209-222; 1983.
27. Mullen, K. D. Hepatic encephalopathy. In: Rector, W. G. ed. Complications of chronic liver disease. St. Louis: Mosby-Year Book; 1992:127-160.
28. Mullen, K. D.; McCullough, A. J. Problems with animal models of chronic liver disease: Suggestions for improvement in standardization. Hepatology 9:500-503; 1989.
29. Nicolas, F.; Rodineau, P.; Rouzioux, J.-M.; Tack, I.; Chabac, S.; Meram, D. Fulminant hepatic failure in poisoning due to ingestion of T61, a veterinary euthanasia drug. Crit. Care Med. 18:573-575; 1990.
30. Norton, N. S.; McConnell, J. R.; Zetterman, R.; Rodriguez-Sierra, J. F. A quantitative evaluation of magnetic resonance image signal changes of the brain in chronic hepatic encephalopathy. J. Hepatol. 21:764-770; 1994.
31. Nozu, F.; Takeyama, N.; Tanaka, T. Changes of hepatic fatty acid metabolism produced by chronic thioacetamide administration in rats. Hepatology 15:1099-1106; 1992.
32. Osada, J.; Aylagas, H.; Miro-Obradors, M. J.; Arce, C.; Palacios-Alaiz, E.; Cascales, M. Effect of acute thioacetamide administration on rat brain phospholipid metabolism. Neurochem. Res. 15:927-931; 1990.
33. Peeling, J.; Shoemaker, L.; Gauthier, T.; Benarroch, A.; Sutherland, G. R.; Minuk, G. Y. Cerebral metabolic and histological effects of thioacetamide-induced liver failure. Am. J. Physiol. 265:G572-G578; 1993.
34. Peleman, R. R.; Gavaler, J. S.; Van Thiel, D. H.; Esquivel, C.; Gordon, R.; Iwatsuki, S.; Starzl, T. E. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 7:484-489; 1987.
35. Porter, W. R.; Gudzinowicz, M. J.; Neal, R. A. Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide-S-oxide in the rat. J. Pharmacol. Exp. Ther. 208:386-391; 1979.
36. Porter, W. R.; Neal, R. A. Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metab. Dis. 6:379-388; 1978.
37. Rikkers, L.; Jenko, P.; Rudman, D.; Freides, D. Subclinical hepatic encephalopathy: Detection, prevalence and relationship to nitrogen metabolism. Gastroenterology 75:462-469; 1978.
38. Schafer, D. F.; Jones, E. A. Hepatic encephalopathy and the γ-aminobutyric acid system. Lancet 1:18-20; 1982.
39. Schafer, D. F.; Jones, E. A. Hepatic encephalopathy. In: Zakim, D., Boyer, T. D., eds. Hepatology. Philadelphia: W. B. Saunders Co.; 1990:447-460.
40. Sherlock, S. Diseases of the liver and biliary system. London: Blackwell Scientific; 1985:91-116.
41. Sherlock, S.; Parbhoo, S. P. The management of acute hepatic failure. Postgrad. Med. J. 47:493; 1971.
42. Sherlock, S. Fulminant hepatic failure. Adv. Int. Med. 38:245-265; 1993.
43. 4 cirrhosis of rats. Hepatology 9:373-379; 1989.
44. Terblanche, J.; Hickman, R. Animal models of fulminant hepatic failure. Dig. Dis. Sci. 36:770-774; 1991.
45. Trewby, P. N.; Hanid, M. A.; Mackenzie, R. L.; Mellon, P. J.; Williams, R. Effects of cerebral oedema and arterial hypotension on cerebral blood flow in an animal model of hepatic failure. Gut 19:999; 1978.
46. Watanabe, A.; Tuchida, T.; Yata, Y.; Kuwabara, Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab. Brain. Dis. 10:239-248; 1995.
47. Wilder, P.; Fisch, H. U.; Schoch, P.; Zimmermann, A.; Schlapfer, T. E.; Reichen, J. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat. Hepatology 18:1459-1464; 1993.
48. 4 in rats. Toxicology 61:241-247; 1990.
49. 4 in rats. Toxicol Appl. Pharmacol. 91:461-468; 1987.
50. Yurdaydin, C.; Hortnagl, H.; Steindl, P.; Zimmermann, C.; Pifl, C.; Singer, E. A.; Roth, E.; Ferenci, P. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology 12:695-700; 1990.
51. Zieve, L. Hepatic encephalopathy. In: Schiff, L.; Schiff, E. R., eds. Diseases of the liver. Philadelphia: J. B. Lippincott; 1985:925-948.
52. Zimmermann, C.; Ferenci, P.; Pifl, C.; Yurdaydin, C.; Ebner, J.; Lassmann, H.; Roth, E.; Hortnagl, H. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: Characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology 9:594-601; 1989.
53. Zimmermann, H. J. Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver. New York: Appleton-Century-Crofts; 1978.